These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22079715)

  • 21. Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.
    Hasegawa S; Furuyama N; Yada S; Hamaura T; Kusai A; Yonemochi E; Terada K
    Int J Pharm; 2007 May; 336(1):82-9. PubMed ID: 17178201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-relationship of physical stability of amorphous dispersions with enthalpy relaxation.
    Bansal SS; Kaushal AM; Bansal AK
    Pharmazie; 2008 Nov; 63(11):812-4. PubMed ID: 19069241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?
    Qian F; Huang J; Zhu Q; Haddadin R; Gawel J; Garmise R; Hussain M
    Int J Pharm; 2010 Aug; 395(1-2):232-5. PubMed ID: 20562003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP; Yu BY; Fu GM; Zhu DN
    J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical stability and relaxation of amorphous indomethacin.
    Vyazovkin S; Dranca I
    J Phys Chem B; 2005 Oct; 109(39):18637-44. PubMed ID: 16853398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigating miscibility and molecular mobility of nifedipine-PVP amorphous solid dispersions using solid-state NMR spectroscopy.
    Yuan X; Sperger D; Munson EJ
    Mol Pharm; 2014 Jan; 11(1):329-37. PubMed ID: 24256090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
    Aso Y; Yoshioka S; Kojima S
    J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation into water interactions with amorphous and milled salbutamol sulphate: the development of predictive models for uptake and recrystallization.
    Grisedale LC; Belton PS; Jamieson MJ; Barker SA; Craig DQ
    Int J Pharm; 2012 Jan; 422(1-2):220-8. PubMed ID: 22100976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
    DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
    Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.
    Ingkatawornwong S; Kaewnopparat N; Tantishaiyakul V
    Pharmazie; 2001 Mar; 56(3):227-30. PubMed ID: 11265589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting physical stability of ternary amorphous solid dispersions using specific mechanical energy in a hot melt extrusion process.
    Hanada M; Jermain SV; Lu X; Su Y; Williams RO
    Int J Pharm; 2018 Sep; 548(1):571-585. PubMed ID: 30006310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
    Matsumoto T; Zografi G
    Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A; Bekmezci S
    Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms.
    Tiţa B; Fuliaş A; Bandur G; Marian E; Tiţa D
    J Pharm Biomed Anal; 2011 Sep; 56(2):221-7. PubMed ID: 21665404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Taylor LS
    Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.
    Ji Y; Paus R; Prudic A; Lübbert C; Sadowski G
    Pharm Res; 2015 Aug; 32(8):2559-78. PubMed ID: 25715696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.